 Data Presented at ESMO Immuno-Oncology Congress SOUTH SAN FRANCISCO, Calif., Dec. 08, 2022 GLOBE NEWSWIRE RAPT Therapeutics, Inc. Nasdaq: RAPT, a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today reported a poster presentation at the ESMO ... The post RAPT Therapeutics Presents Update from its Phase 12 Clinical... 